论文部分内容阅读
目的本次研究分析黄芪注射液治疗病毒性心肌炎对于患者心肌肌钙蛋白Ⅰ与心肌酶指标的影响。方法从濮阳市中医院2016年6月至2016年12月收治的病毒性心肌炎患者中选取80例,按照随机抽样法将其分为对照组与观察组,对照组采用常规对症治疗,观察组患者在其治疗基础上采用黄芪注射液治疗。对比两组患者治疗前后的心肌肌钙蛋白Ⅰ与心肌酶指标。结果两组患者的治疗前的肌酸激酶指标、肌酸激酶同工酶指标、心肌肌钙蛋白Ⅰ指标等差异均无统计学意义(P>0.05);观察组患者治疗后的肌酸激酶指标、肌酸激酶同工酶指标、心肌肌钙蛋白Ⅰ指标均低于对照组患者,差异有统计学意义(P<0.05);观察组治疗总有效率90.2%明显高于对照组(69.2%),差异有统计学意义(P<0.05)。结论黄芪注射液治疗病毒性心肌炎具有显著的效果,可有效改善患者心肌肌钙蛋白Ⅰ与心肌酶指标,可作为临床首选治疗方法推广。
Objective This study analyzed the effects of Astragalus injection on viral myocarditis in patients with cardiac troponin Ⅰ and myocardial enzyme index. Methods Eighty patients were selected from patients with viral myocarditis admitted from June 2016 to December 2016 in Puyang Municipal Hospital of Traditional Chinese Medicine. They were divided into control group and observation group according to random sampling method. Patients in observation group were treated with conventional symptomatic treatment. On the basis of its treatment with Astragalus injection treatment. The levels of cardiac troponin I and myocardial enzymes before and after treatment were compared between two groups. Results Before treatment, creatine kinase, creatine kinase, and cardiac troponin I were not significantly different between the two groups (P> 0.05). The creatine kinase level , Creatine kinase isoenzyme index and cardiac troponin I index were lower than those in the control group (P <0.05). The total effective rate in the observation group was 90.2% significantly higher than that in the control group (69.2%) , The difference was statistically significant (P <0.05). Conclusion Astragalus injection treatment of viral myocarditis has a significant effect, which can effectively improve cardiac troponin Ⅰ and myocardial enzyme markers, can be used as the preferred method of clinical treatment.